Search research articles
Contact Us
Filters
Showing results (11-20 of 202) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
EML4-ALK: honing in on a new target in non-small-cell lung cancer
Leora Horn, William Pao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2011
How genetically engineered mouse tumor models provide insights into human cancers
Katerina Politi, William Pao
Nature Medicine
|
April 11, 2018
Catalyzing the field of precision oncology, one basket at a time
William Pao, Imola Fodor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 16, 2013
Further advances in genetically informed lung cancer medicine
Caroline Nebhan, William Pao
Cancer Biology & Therapy
|
November 19, 2005
Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: is timing important?
Gregory J Riely, William Pao
Science Translational Medicine
|
February 11, 2012
Escaping ALK inhibition: mechanisms of and strategies to overcome resistance
Christine M Lovly, William Pao
Cancer Discovery
|
April 8, 2015
Old Habits Die Hard: Addiction of BRAF-Mutant Cancer Cells to MAP Kinase Signaling
Catherine B Meador, William Pao
Nature Medicine
|
March 8, 2012
Chipping away at the lung cancer genome
William Pao, Katherine E Hutchinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions
William Pao, Vincent A Miller
Cancer Discovery
|
February 13, 2013
Maximizing the benefits of off-target kinase inhibitor activity
Monica Red Brewer, William Pao
Page
of 21
Search research articles
Search
Showing results (11-20 of 202) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
EML4-ALK: honing in on a new target in non-small-cell lung cancer
Leora Horn, William Pao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2011
How genetically engineered mouse tumor models provide insights into human cancers
Katerina Politi, William Pao
Nature Medicine
|
April 11, 2018
Catalyzing the field of precision oncology, one basket at a time
William Pao, Imola Fodor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 16, 2013
Further advances in genetically informed lung cancer medicine
Caroline Nebhan, William Pao
Cancer Biology & Therapy
|
November 19, 2005
Combining EGFR targeted therapy with chemotherapy in pancreatic cancer: is timing important?
Gregory J Riely, William Pao
Science Translational Medicine
|
February 11, 2012
Escaping ALK inhibition: mechanisms of and strategies to overcome resistance
Christine M Lovly, William Pao
Cancer Discovery
|
April 8, 2015
Old Habits Die Hard: Addiction of BRAF-Mutant Cancer Cells to MAP Kinase Signaling
Catherine B Meador, William Pao
Nature Medicine
|
March 8, 2012
Chipping away at the lung cancer genome
William Pao, Katherine E Hutchinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions
William Pao, Vincent A Miller
Cancer Discovery
|
February 13, 2013
Maximizing the benefits of off-target kinase inhibitor activity
Monica Red Brewer, William Pao
Page
of 21